Sainor Life Sciences Private Limited
Sainor Life Sciences Private Limited is a Private Non-govt company company incorporated in 2007 and based in Telangana, India. Sainor Life Sciences Private Limited operates in Allopathic pharmaceutical preparations, manufacturing (NIC 24232) with authorized capital of ₹14.00 Cr and paid-up capital of ₹13.95 Cr. For 2018-19, the company reported revenue of ₹55.52 Cr and profit after tax of ₹74.76 L. The board has 4 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
SAINOR LIFE SCIENCES PRIVATE LIMITED is the legal entity of Sainor Life Sciences.
Quick facts
Directors
4 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +9d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Sainor Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 189568029 | State Bank of India(Bank) | ₹20.99 Cr | 12 Mar 2020 | Open |
| 105088172 | Kotak Mahindra Bank Ltd(Bank) | ₹24.46 Cr | 12 Mar 2021 | Satisfied |
| 318249718 | ICICI Bank Ltd(Bank) | ₹98.34 L | 27 Jan 2022 | Open |
| 683096570 | Kotak Mahindra Bank Ltd(Bank) | ₹19.52 Cr | 12 Mar 2022 | Open |
| 544713368 | HDFC Bank Ltd(Bank) | ₹2.18 Cr | 27 Jan 2021 | Satisfied |
Charge IDs, lenders & amounts for Sainor Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2018-19 | — | ||||
| 2017-18 | — |
Detailed Financials
2 FYs| Line item | 2018-19 | 2017-18 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2018-19 | +94.0% | — | — | |
| Profit after Tax2018-19 | +63.0% | — | — | |
| Net Worth2018-19 | +98.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +1.02% | — | +6.83% | +1.02% | — | |||
| 2018-19 | +1.35% | +27.68% | +10.21% | +1.62% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,55,62,827 | 60.86% |
| Institutional Investors | 1 | 15,91,913 | 3.79% |
| Public & Others | 54 | 1,48,49,790 | 35.35% |
Promoter, institutional & public holding for Sainor Life Sciences Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
55 peersEvents & timeline
5External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.